RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 76 filers reported holding RECRO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,995,000 | +35.7% | 700,000 | 0.0% | 0.46% | +28.9% |
Q3 2020 | $1,470,000 | -77.3% | 700,000 | -36.7% | 0.36% | -70.9% |
Q1 2019 | $6,480,000 | -43.0% | 1,105,809 | -30.9% | 1.22% | -44.9% |
Q4 2018 | $11,360,000 | +20.2% | 1,600,000 | +20.3% | 2.22% | +37.3% |
Q3 2018 | $9,454,000 | +112.2% | 1,329,611 | +49.8% | 1.62% | +94.0% |
Q2 2018 | $4,456,000 | – | 887,700 | – | 0.83% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |